Tag archives: Andrea Dominic
FDA Considerations Put Compounding Pharmacy Services at Risk
A recent report from the National Academies of Sciences, Engineering, and Medicine (NASEM) titled, “The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use,” has raised concerns for the staff of San Ysidro Pharmacy (SYP) and other compounding pharmacies around the nation. The report included a recommendation for across-the-board restrictions […]
